Concepts (102)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lymphedema | 4 | 2022 | 534 | 1.130 |
Why?
|
Lymph Node Excision | 5 | 2022 | 1262 | 1.080 |
Why?
|
Mastectomy, Segmental | 2 | 2020 | 956 | 0.830 |
Why?
|
Breast Neoplasms | 14 | 2024 | 20827 | 0.740 |
Why?
|
Mastectomy, Subcutaneous | 1 | 2020 | 46 | 0.710 |
Why?
|
Microsurgery | 1 | 2019 | 785 | 0.480 |
Why?
|
Axilla | 4 | 2022 | 597 | 0.470 |
Why?
|
Neoadjuvant Therapy | 1 | 2021 | 2727 | 0.380 |
Why?
|
Mammaplasty | 1 | 2020 | 1204 | 0.360 |
Why?
|
Sentinel Lymph Node Biopsy | 3 | 2022 | 710 | 0.350 |
Why?
|
Lymph Nodes | 1 | 2017 | 3476 | 0.260 |
Why?
|
Gallbladder Diseases | 1 | 2003 | 125 | 0.220 |
Why?
|
Transducers | 1 | 2023 | 253 | 0.210 |
Why?
|
Cholecystectomy, Laparoscopic | 1 | 2003 | 230 | 0.200 |
Why?
|
Spectrum Analysis | 1 | 2022 | 454 | 0.180 |
Why?
|
Breast | 2 | 2020 | 1970 | 0.170 |
Why?
|
Quality of Life | 2 | 2020 | 12788 | 0.170 |
Why?
|
Esthetics | 1 | 2020 | 305 | 0.160 |
Why?
|
Lead | 1 | 2023 | 852 | 0.160 |
Why?
|
Postoperative Complications | 1 | 2019 | 15281 | 0.150 |
Why?
|
Breast Implants | 1 | 2020 | 387 | 0.140 |
Why?
|
Paresis | 2 | 2007 | 180 | 0.140 |
Why?
|
Insulin-Like Growth Factor Binding Proteins | 1 | 2016 | 216 | 0.130 |
Why?
|
Insulin-Like Growth Factor Binding Protein 5 | 1 | 2014 | 27 | 0.120 |
Why?
|
Hospitals, Special | 1 | 2014 | 101 | 0.110 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2021 | 3480 | 0.110 |
Why?
|
Cosmetic Techniques | 1 | 2014 | 135 | 0.100 |
Why?
|
Mastectomy | 2 | 2024 | 1793 | 0.100 |
Why?
|
Wound Healing | 2 | 2019 | 2776 | 0.100 |
Why?
|
Surgical Flaps | 1 | 2020 | 1629 | 0.100 |
Why?
|
Telomere | 1 | 2016 | 910 | 0.090 |
Why?
|
Spinal Neoplasms | 2 | 2007 | 760 | 0.090 |
Why?
|
Female | 14 | 2024 | 380020 | 0.090 |
Why?
|
Disease-Free Survival | 1 | 2020 | 6895 | 0.090 |
Why?
|
Lymphatic Metastasis | 1 | 2017 | 2924 | 0.080 |
Why?
|
Turkey | 3 | 2016 | 237 | 0.080 |
Why?
|
Vitamin D | 1 | 2021 | 3222 | 0.080 |
Why?
|
Survival Rate | 2 | 2020 | 12786 | 0.080 |
Why?
|
Patient Selection | 1 | 2020 | 4210 | 0.080 |
Why?
|
Patient Satisfaction | 1 | 2020 | 3391 | 0.080 |
Why?
|
Treatment Outcome | 3 | 2021 | 63042 | 0.070 |
Why?
|
Retrospective Studies | 3 | 2021 | 77410 | 0.070 |
Why?
|
Humans | 13 | 2024 | 743811 | 0.060 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2014 | 2938 | 0.060 |
Why?
|
Prognosis | 3 | 2020 | 29052 | 0.060 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2007 | 623 | 0.060 |
Why?
|
Middle Aged | 7 | 2020 | 213241 | 0.060 |
Why?
|
Aged | 5 | 2020 | 163178 | 0.060 |
Why?
|
Adult | 6 | 2020 | 213889 | 0.050 |
Why?
|
Gallbladder | 1 | 2003 | 302 | 0.050 |
Why?
|
Clinical Trials as Topic | 1 | 2017 | 7908 | 0.050 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 11524 | 0.050 |
Why?
|
Follow-Up Studies | 2 | 2020 | 39001 | 0.050 |
Why?
|
Paclitaxel | 1 | 2007 | 1705 | 0.040 |
Why?
|
Cohort Studies | 2 | 2019 | 40545 | 0.040 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2014 | 8430 | 0.040 |
Why?
|
Rats, Inbred F344 | 2 | 2007 | 862 | 0.030 |
Why?
|
Drug Delivery Systems | 1 | 2007 | 2217 | 0.030 |
Why?
|
Survival Analysis | 3 | 2016 | 10251 | 0.030 |
Why?
|
Young Adult | 1 | 2020 | 56392 | 0.030 |
Why?
|
Neoplasm Transplantation | 2 | 2007 | 2085 | 0.030 |
Why?
|
Frozen Sections | 1 | 2014 | 155 | 0.030 |
Why?
|
Restriction Mapping | 1 | 2014 | 878 | 0.030 |
Why?
|
Medical Oncology | 1 | 2024 | 2267 | 0.030 |
Why?
|
Aged, 80 and over | 2 | 2014 | 57744 | 0.030 |
Why?
|
Ultrasonography | 1 | 2023 | 5986 | 0.020 |
Why?
|
Neoplasm Staging | 2 | 2014 | 11036 | 0.020 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2014 | 890 | 0.020 |
Why?
|
Mutation | 1 | 2014 | 29777 | 0.020 |
Why?
|
Biopsy, Needle | 1 | 2014 | 1639 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2014 | 2883 | 0.020 |
Why?
|
Hospitals, University | 1 | 2009 | 570 | 0.020 |
Why?
|
Injections, Intralesional | 1 | 2007 | 276 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2014 | 3617 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2014 | 21733 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2014 | 2703 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2014 | 6170 | 0.010 |
Why?
|
Abortion, Spontaneous | 1 | 2009 | 544 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2014 | 6539 | 0.010 |
Why?
|
DNA Methylation | 1 | 2016 | 4286 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2014 | 4803 | 0.010 |
Why?
|
Estrogen Replacement Therapy | 1 | 2009 | 1203 | 0.010 |
Why?
|
Rats | 2 | 2007 | 24250 | 0.010 |
Why?
|
Cell Line, Tumor | 2 | 2007 | 16674 | 0.010 |
Why?
|
Breast Feeding | 1 | 2009 | 1338 | 0.010 |
Why?
|
Polymers | 1 | 2007 | 1621 | 0.010 |
Why?
|
Early Detection of Cancer | 1 | 2014 | 3089 | 0.010 |
Why?
|
Adenocarcinoma | 2 | 2007 | 6363 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2014 | 12354 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2014 | 15067 | 0.010 |
Why?
|
Disease Progression | 1 | 2014 | 13273 | 0.010 |
Why?
|
Odds Ratio | 1 | 2009 | 9848 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2007 | 10940 | 0.010 |
Why?
|
Logistic Models | 1 | 2009 | 13404 | 0.010 |
Why?
|
Risk Assessment | 1 | 2014 | 23327 | 0.010 |
Why?
|
Smoking | 1 | 2009 | 8984 | 0.010 |
Why?
|
Age Factors | 1 | 2009 | 18355 | 0.010 |
Why?
|
Body Mass Index | 1 | 2009 | 12718 | 0.010 |
Why?
|
Prospective Studies | 1 | 2014 | 53250 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2007 | 18027 | 0.010 |
Why?
|
Animals | 2 | 2007 | 168660 | 0.000 |
Why?
|
Risk Factors | 1 | 2009 | 72252 | 0.000 |
Why?
|
Concepts
(102)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(1)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_